This is a routine investor presentation filing with no new material data. Traders should monitor for future clinical trial results or financial guidance updates in subsequent filings. The R&D Day may generate discussion but does not provide a trading catalyst.
Price Chart
Executive Summary
Immunic, Inc. filed an 8-K announcing a Relapsing Multiple Sclerosis (RMS) Research and Development Day webinar held on September 9, 2026. The filing includes a presentation (Exhibit 99.1) focused on the company's RMS development program, but no new financial data, clinical results, or guidance were disclosed in the filing text. This is a routine investor-relations event with no material new information for traders.
Key Facts
- Immunic hosted an RMS R&D Day webinar on September 9, 2026, from 11:00 a.m. to 12:30 p.m. ET.
- The presentation attached as Exhibit 99.1 focuses on the company's Relapsing Multiple Sclerosis program.
- No financial results, clinical data, or guidance updates were disclosed in the filing.
- The filing is a Regulation FD disclosure of an investor presentation.
Financial Impact
No financial data disclosed in the filing.
Risk Factors
- No new clinical or financial data was provided, limiting actionable information.
- Forward-looking statements in the filing are subject to risks outlined in prior SEC filings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193805-26-001196 |
| Document: e665768_8k-immunic.htm | 0001193805-26-001196 |
| Document: 0001193805-26-001196-index-headers.html | 0001193805-26-001196 |
| Document: 0001193805-26-001196-index.html | 0001193805-26-001196 |
| Document: 0001193805-26-001196.txt | 0001193805-26-001196 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 6w ago | 8-K | $12.19 | awaiting T+60 | — | $7.28 (−40.28%) |
Aug 11, 2026 11w ago | 8-K | $15.48 | awaiting T+60 | — | $7.28 (−52.97%) |
Jul 14, 2026 15w ago | 8-K | $14.69 $7.63 | ▼ −48.06% | ▼ −51.44% | $7.28 (−50.44%) |
Jun 29, 2026 17w ago | 8-K | $15.37 $9.37 | ▼ −39.04% | ▼ −42.60% | $7.28 (−52.64%) |
May 19, 2026 22w ago | 3 | $11.55 $16.06 | ▲ +39.05% | ▲ +34.04% | $7.28 (−36.97%) |
May 19, 2026 23w ago | 8-K | $11.60 $16.58 | ▲ +42.93% | ▲ +36.64% | $7.28 (−37.24%) |
Apr 30, 2026 25w ago | S-3/A | $9.65 $13.34 | ▼ −38.24% | ▼ −35.17% | $7.28 (+24.56%) |
Apr 23, 2026 26w ago | 8-K | $9.18 $15.00 | ▲ +63.40% | ▲ +58.38% | $7.28 (−20.70%) |
Apr 14, 2026 27w ago | 8-K | $11.10 $14.77 | ▲ +33.06% | ▲ +24.93% | $7.28 (−34.41%) |
Apr 10, 2026 28w ago | 8-K | $12.20 $14.77 | ▲ +21.07% | ▲ +12.14% | $7.28 (−40.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers